Endo International plc is a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded and generic pharmaceutical and non-pharmaceutical products. The Company operates through three segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals and International Pharmaceuticals. Endo's headquarters are in Dublin, Ireland, and its operational headquarters are in Malvern, Pennsylvania, USA. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, Pennsylvania. The Company's ordinary shares are listed on the NASDAQ Global Select Market under the symbol ENDP.